Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Lucid Diagnostics Inc. - Common Stock (NQ:LUCD)

1.200 -0.020 (-1.64%)
Streaming Delayed Price Updated: 11:47 AM EST, Feb 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Lucid Diagnostics Inc. - Common Stock

< Previous 1 2 Next >
News headline image
Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team
From PAVmed Inc. and Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
From Lucid Diagnostics Inc. PAVmed Inc.
Via Business Wire
News headline image
PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results
From PAVmed Inc. and Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021
From PAVmed Inc. and Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics’ EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year” Award
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering
From Lucid Diagnostics Inc.
Via Business Wire
News headline image
Lucid Diagnostics Announces Pricing of Initial Public Offering
From PAVmed Inc.
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.